Bausch + Lomb is moving beyond eye-care products with an AI platform built around the patient journey
Bausch + Lomb’s Orphia brings AI to cataract education, but adoption will depend on workflow integration, validation, privacy and trust.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Is Vilo Signal OS truly different from Oura Advisor and WHOOP’s proactive AI?
Discover how Vilo Signal OS plans to turn smart ring data into proactive health guidance, and why validation, privacy and trust will decide its future.
Medical Devices & Diagnostics
Everlab’s AU$65m Series A raises the stakes for preventive health platforms
Find out how Everlab’s AU$65m Series A could reshape AI preventive healthcare, diagnostics, patient data and scalable care access.
Medical Devices & Diagnostics
What Dassault Systèmes’ PariSanté Campus partnership reveals about the future of health data sovereignty
See how Dassault Systèmes and PariSanté Campus could reshape sovereign healthcare AI in Europe. Read the industry analysis.
Pharma & Biotech
Why Semble’s £30m Series C could reshape private healthcare software in Europe
Find out how Semble’s £30M Series C could reshape connected healthcare software and private clinic workflows across Europe.
Pharma & Biotech
How Massive Bio’s Reticulum Nexus suite is targeting the hidden bottlenecks in cancer trials
Can Massive Bio’s Reticulum Nexus suite close oncology trial access gaps? Find out how AI agents may reshape cancer trial navigation today!
Medical Devices & Diagnostics
FDA breakthrough status gives Coredio’s AI heart failure platform a faster regulatory path
Coredio’s AI heart failure platform may bring hemodynamic insight into home care. See why FDA breakthrough status matters now.
Features & Analysis
A workers’ comp portal may not sound flashy. For orthopaedic care delays, it could matter
Find out how DMOS Orthopaedic Centers’ new workers’ comp portal could speed referrals, reduce delays and improve injury-care coordination.
Pharma & Biotech
Phoenix and Raven launch direct-to-patient generic semaglutide after Health Canada approval
Generic semaglutide is cheaper, but access is now the real battleground. Phoenix and Raven are testing Canada’s GLP-1 telehealth future.
Medical Devices & Diagnostics
Why Glooko’s FDA-cleared EndoTool IV Cloud could reshape hospital glycemic management
Insulin dosing is moving to the cloud. Glooko’s FDA clearance raises bigger questions on hospital workflow, safety, and scale.